Scott Berry presents at the “Transforming Drug Development – Delivering Innovation and Efficiency through Adaptive Clinical Trials” conference that was co-sponsored by Berry Consultants.

Join us for three upcoming events this month focused on clinical trial simulation and adaptive trial design, including two webinars on November 14 and 15, and a conference on November 29-30, where experts will share insights and benefits of these innovative approaches.

Scott Berry presents at the Royal Statistical Society’s, “PSI Debate: This house believes that pharmaceutical drug development and regulation should become fully Bayesian”.

Berry Consultants is co-sponsoring the "Transforming Drug Development" conference on October 22nd in Bethesda, Maryland, featuring key presentations from team members on adaptive clinical trials, and interested attendees can register at http://www.InnovationsInClinicalTrials.com/.

SIGMEDD, a statistics interest group within the American Statistical Association focused on medical devices and diagnostics, is seeking ASA members' support through signatures for its transition to a full section, with the current Chair-Elect encouraging participation via a petition.

Berry Consultants is co-sponsoring the "Transforming Drug Development" conference on October 22nd in Bethesda, Maryland, featuring key presentations from team members on adaptive clinical trials, and interested attendees can register at http://www.InnovationsInClinicalTrials.com/.